
Activity Description
This CME-accredited lunch symposium explores the latest CHAMPION-AF trial data and its clinical impact on left atrial appendage closure. Attendees will gain insights into LAAC versus NOACs for stroke protection, contextualizing CHAMPION findings within the body of evidence. This session will also include discussions on the further evolution of the therapy, optimal post-implant drug regimens, and best practices for procedural imaging.
Date
Friday, April 24, 2026
Times
• 12:00 – 12:30 PM CDT: Check-In and Lunch
• 12:30 – 2:30 PM CDT : Educational Programming
Location
Hyatt Regency McCormick Place • Room S406A
2233 S Dr. Martin Luther King Jr. Drive, Chicago, IL
Agenda
|
Agenda |
||
|
12:00 – 12:30 PM |
Check-In and Lunch |
|
|
12:30 – 12:35 PM |
Welcome and Introductions |
|
|
12:35 – 12:55 PM |
CHAMPION-AF Clinical Trial: Results and Impact on Practice |
|
| 12:55 – 1:15 PM |
Translating Trial Data: LAAC Versus NOACs for Stroke Protection in AF Patients |
|
|
1:15 – 1:35 PM |
Imaging Modalities to Guide Left Atrial Appendage Closure |
|
|
1:35 – 1:55 PM |
Optimal Drug Regimens after LAAC |
|
|
1:55 – 2:30 PM |
Panel Discussion with Q&A |
|
Commercial Support
This activity is supported through an educational grant from:
Boston Scientific
Organizer and Joint CME Provider
MediaSphere Medical, LLC
Faculty
|
Moderator |
|||
![]() |
Moussa Mansour, MD |
|
|
|
Presenters and Panelists |
|||
![]() |
David DeLurgio, MD |
![]() |
Walid Saliba, MD |
![]() |
James Freeman, MD |
![]() |
Manish Shah, MD |
CME Accreditation
Activity Goal
This activity is designed to address the following core and team competencies:
Patient care, medical knowledge, practice-based learning and improvement, interprofessional collaboration, and roles and responsibilities.
Target Audience
The symposium is intended to meet the educational needs of electrophysiologists, cardiologists, fellows in training, allied healthcare professionals, and other physician groups with a clinical interest in the management of Afib and stroke prevention.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
- Examine the latest CHAMPION-AF trial data and its clinical impact on LAAC.
- Review LAAC versus NOAC for stroke protection.
- Assess the evolution of LAAC, optimal post-implant drug regimens, and best practices for procedural imaging.
Accreditation Statement
MediaSphere Medical and Ciné-Med have planned and implemented this activity to improve patient care. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians. This educational activity is accredited for a maximum of 2.00 AMA PRA CATEGORY 1 Credits™. Nurses and Other Healthcare Professionals. All other healthcare professionals will receive a Certificate of Participation. Consult your professional licensing board for information on the applicability and acceptance of Certificates of Participation for activities designated for AMA PRA Category 1 Credits™.
Claiming Credits
CME Credits can be claimed immediately after the symposium. One electronically issued certificate will cover all CME Credits earned through participation. At the end of the activity, a notification will be sent to the registration email with instructions on how to claim credits. The Program Guide, distributed at the symposium, will also include directions for claiming credits.
Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.
It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.
MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.
Joint Providership:
MediaSphere Medical, LLC and Ciné-Med
“This program is not part of the Heart Rhythm 2026 Official Scientific Sessions as planned
by the Heart Rhythm Society Scientific Sessions Program Committee.
The event is neither sponsored nor endorsed by the Heart Rhythm Society”





